nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Angioedema—Prednisolone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Regadenoson—Myocardial infarction—Prednisone—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Regadenoson—Malaise—Prednisolone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Regadenoson—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Regadenoson—Syncope—Prednisolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Regadenoson—Eye disorder—Betamethasone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Regadenoson—Eye disorder—Dexamethasone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Regadenoson—Asthma—Methotrexate—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Regadenoson—Angiopathy—Dexamethasone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Regadenoson—Angiopathy—Betamethasone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Regadenoson—Convulsion—Prednisolone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Regadenoson—Hypertension—Prednisolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Regadenoson—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Regadenoson—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Regadenoson—Bradycardia—Prednisone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Regadenoson—Discomfort—Prednisolone—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Regadenoson—Angioedema—Triamcinolone—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Regadenoson—Angioedema—Methylprednisolone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Regadenoson—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Regadenoson—Erythema—Dexamethasone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Regadenoson—Erythema—Betamethasone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Regadenoson—Malaise—Triamcinolone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Regadenoson—Malaise—Methylprednisolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Regadenoson—Syncope—Triamcinolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Regadenoson—Syncope—Methylprednisolone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Regadenoson—Connective tissue disorder—Prednisone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Regadenoson—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00335	0.00335	CcSEcCtD
Regadenoson—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00335	0.00335	CcSEcCtD
Regadenoson—Shock—Prednisolone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Regadenoson—Cough—Triamcinolone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Regadenoson—Convulsion—Triamcinolone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Regadenoson—Tachycardia—Prednisolone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Regadenoson—Convulsion—Methylprednisolone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Regadenoson—Hypertension—Triamcinolone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Regadenoson—Hypertension—Methylprednisolone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Regadenoson—Myalgia—Triamcinolone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Regadenoson—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Regadenoson—Myalgia—Methylprednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Regadenoson—Eye disorder—Prednisone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Regadenoson—Anxiety—Methylprednisolone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Regadenoson—Flushing—Prednisone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Regadenoson—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Regadenoson—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Regadenoson—Discomfort—Triamcinolone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Regadenoson—Discomfort—Methylprednisolone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Regadenoson—Renal failure—Methotrexate—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Regadenoson—Angioedema—Betamethasone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Regadenoson—Angioedema—Dexamethasone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Regadenoson—Angiopathy—Prednisone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Regadenoson—Immune system disorder—Prednisone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Regadenoson—Malaise—Betamethasone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Regadenoson—Malaise—Dexamethasone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Regadenoson—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Regadenoson—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Regadenoson—Syncope—Dexamethasone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Regadenoson—Syncope—Betamethasone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Regadenoson—Shock—Triamcinolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Regadenoson—Insomnia—Prednisolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Regadenoson—Shock—Methylprednisolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Regadenoson—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Regadenoson—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Regadenoson—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Regadenoson—Paraesthesia—Prednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Regadenoson—Tachycardia—Triamcinolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Regadenoson—Mental disorder—Prednisone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Regadenoson—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Regadenoson—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Regadenoson—Erythema—Prednisone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Regadenoson—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Regadenoson—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Regadenoson—Convulsion—Betamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Regadenoson—Convulsion—Dexamethasone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Regadenoson—Hypertension—Betamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Regadenoson—Hypertension—Dexamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Regadenoson—Myalgia—Dexamethasone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Regadenoson—Myalgia—Betamethasone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Regadenoson—Anxiety—Dexamethasone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Regadenoson—Anxiety—Betamethasone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Regadenoson—Discomfort—Dexamethasone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Regadenoson—Discomfort—Betamethasone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Regadenoson—Hypotension—Methylprednisolone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Regadenoson—Pain—Prednisolone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Regadenoson—Vision blurred—Prednisone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Regadenoson—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Regadenoson—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Regadenoson—Insomnia—Triamcinolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Regadenoson—Insomnia—Methylprednisolone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Regadenoson—Ill-defined disorder—Prednisone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Regadenoson—Paraesthesia—Triamcinolone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Regadenoson—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Regadenoson—Shock—Betamethasone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Regadenoson—Shock—Dexamethasone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Regadenoson—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Regadenoson—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Regadenoson—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Regadenoson—Tachycardia—Dexamethasone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Regadenoson—Tachycardia—Betamethasone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Regadenoson—Angioedema—Prednisone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Regadenoson—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Regadenoson—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Regadenoson—Malaise—Prednisone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Regadenoson—Eye disorder—Methotrexate—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Regadenoson—Syncope—Prednisone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Regadenoson—Tinnitus—Methotrexate—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Regadenoson—Urticaria—Prednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Regadenoson—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Regadenoson—Pain—Triamcinolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Regadenoson—Hypotension—Dexamethasone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Regadenoson—Hypotension—Betamethasone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Regadenoson—Angiopathy—Methotrexate—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Regadenoson—Immune system disorder—Methotrexate—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Regadenoson—Convulsion—Prednisone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Regadenoson—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Regadenoson—Hypertension—Prednisone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Regadenoson—Arthralgia—Prednisone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Regadenoson—Myalgia—Prednisone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Regadenoson—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Regadenoson—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Regadenoson—Anxiety—Prednisone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Regadenoson—Insomnia—Dexamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Regadenoson—Insomnia—Betamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Regadenoson—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Regadenoson—Paraesthesia—Betamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Regadenoson—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Regadenoson—Discomfort—Prednisone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Regadenoson—Mental disorder—Methotrexate—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Regadenoson—Erythema—Methotrexate—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Regadenoson—Urticaria—Triamcinolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Regadenoson—Urticaria—Methylprednisolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Regadenoson—Dysgeusia—Methotrexate—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Regadenoson—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Regadenoson—Shock—Prednisone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Regadenoson—Pain—Dexamethasone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Regadenoson—Pain—Betamethasone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Regadenoson—Nervous system disorder—Prednisone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Regadenoson—Tachycardia—Prednisone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Regadenoson—Skin disorder—Prednisone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Regadenoson—Vision blurred—Methotrexate—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Regadenoson—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Regadenoson—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Regadenoson—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Regadenoson—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Regadenoson—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Regadenoson—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Regadenoson—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Regadenoson—Malaise—Methotrexate—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Regadenoson—Urticaria—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Regadenoson—Urticaria—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Regadenoson—Dizziness—Prednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Regadenoson—Asthenia—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Regadenoson—Abdominal pain—Betamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Regadenoson—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Regadenoson—Asthenia—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Regadenoson—Insomnia—Prednisone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Regadenoson—Paraesthesia—Prednisone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Regadenoson—Cough—Methotrexate—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Regadenoson—Convulsion—Methotrexate—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Regadenoson—Arthralgia—Methotrexate—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Regadenoson—Chest pain—Methotrexate—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Regadenoson—Myalgia—Methotrexate—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Regadenoson—Rash—Prednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Regadenoson—Dermatitis—Prednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Regadenoson—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Regadenoson—Headache—Prednisolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Regadenoson—Discomfort—Methotrexate—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Regadenoson—Dizziness—Triamcinolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Regadenoson—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Regadenoson—Dizziness—Methylprednisolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Regadenoson—Asthenia—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Regadenoson—Asthenia—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Regadenoson—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Regadenoson—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Regadenoson—Nausea—Prednisolone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Regadenoson—Skin disorder—Methotrexate—psoriatic arthritis	0.002	0.002	CcSEcCtD
Regadenoson—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Regadenoson—Vomiting—Triamcinolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Regadenoson—Vomiting—Methylprednisolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Regadenoson—Rash—Triamcinolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Regadenoson—Dermatitis—Triamcinolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Regadenoson—Rash—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Regadenoson—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Regadenoson—Urticaria—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Regadenoson—Headache—Triamcinolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Regadenoson—Headache—Methylprednisolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Regadenoson—Abdominal pain—Prednisone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Regadenoson—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Regadenoson—Diarrhoea—Betamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Regadenoson—Hypotension—Methotrexate—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Regadenoson—Dizziness—Betamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Regadenoson—Dizziness—Dexamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Regadenoson—Insomnia—Methotrexate—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Regadenoson—Nausea—Triamcinolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Regadenoson—Paraesthesia—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Regadenoson—Nausea—Methylprednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Regadenoson—Dyspnoea—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Regadenoson—Somnolence—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Regadenoson—Vomiting—Betamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Regadenoson—Vomiting—Dexamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Regadenoson—Rash—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Regadenoson—Rash—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Regadenoson—Dermatitis—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Regadenoson—Dermatitis—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Regadenoson—Headache—Dexamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Regadenoson—Headache—Betamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Regadenoson—Asthenia—Prednisone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Regadenoson—Pain—Methotrexate—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Regadenoson—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Regadenoson—Diarrhoea—Prednisone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Regadenoson—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Regadenoson—Nausea—Dexamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Regadenoson—Nausea—Betamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Regadenoson—Urticaria—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Regadenoson—Dizziness—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Regadenoson—Abdominal pain—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Regadenoson—Vomiting—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Regadenoson—Rash—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Regadenoson—Dermatitis—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Regadenoson—Headache—Prednisone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Regadenoson—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Regadenoson—Asthenia—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Regadenoson—Nausea—Prednisone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Regadenoson—Diarrhoea—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Regadenoson—Dizziness—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Regadenoson—Vomiting—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Regadenoson—Rash—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Regadenoson—Dermatitis—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Regadenoson—Headache—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Regadenoson—Nausea—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
